+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Specialty Drug Distribution Market Research Report by Distribution Type, by Indication, by Distribution Channel, by Region - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 4807807
  • Report
  • June 2021
  • Region: Global
  • 182 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Specialty Drug Distribution Market will Grow to USD 3,053.88 Million by 2025, at a CAGR of 13.96%

FEATURED COMPANIES

  • Alliance Healthcare
  • Cardinal Health, Inc.
  • CuraScript, Inc.
  • CVS Health Corporation
  • Diplomat Pharmacy, Inc.
  • McKesson Corporation
  • MORE
The Global Specialty Drug Distribution Market size was estimated at USD 1,588.44 Million in 2020 and expected to reach USD 1,807.37 Million in 2021, at a Compound Annual Growth Rate (CAGR) 13.96% to reach USD 3,053.88 Million by 2025.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2025 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Specialty Drug Distribution to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Distribution Type, the Specialty Drug Distribution Market was studied across Clinic/ASCs, Home Health, Inpatient, Mail Delivery, Outpatient, and Retail.
  • Based on Type, the Specialty Drug Distribution Market was studied across Full line Wholesalers and Specialty Distributors.
  • Based on Indication, the Specialty Drug Distribution Market was studied across AIDS, Hemophilia, Multiple Sclerosis, Oncology, and Rheumatoid Arthritis.
  • Based on Distribution Channel, the Specialty Drug Distribution Market was studied across Hospitals & Care Providers, Independent Pharmacies, Large Chain Pharmacies, Online Stores, and Specialty Pharmacies.
  • Based on Region, the Specialty Drug Distribution Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Specialty Drug Distribution Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Specialty Drug Distribution Market, including Alliance Healthcare, AmerisourceBergen Corporation, Cardinal Health, Inc., CuraScript, Inc., CVS Health Corporation, Diplomat Pharmacy, Inc., Express Scripts Holding Company, McKesson Corporation, Mediceo Paltac Holdings Co., Ltd., Pfizer Inc., Shanghai Pharma, Sinopharm, and Smith Drug Co., Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Specialty Drug Distribution Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Specialty Drug Distribution Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Specialty Drug Distribution Market?
4. What is the competitive strategic window for opportunities in the Global Specialty Drug Distribution Market?
5. What are the technology trends and regulatory frameworks in the Global Specialty Drug Distribution Market?
6. What is the market share of the leading vendors in the Global Specialty Drug Distribution Market?
7. What modes and strategic moves are considered suitable for entering the Global Specialty Drug Distribution Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Alliance Healthcare
  • Cardinal Health, Inc.
  • CuraScript, Inc.
  • CVS Health Corporation
  • Diplomat Pharmacy, Inc.
  • McKesson Corporation
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Distribution Type Outlook
3.4. Type Outlook
3.5. Indication Outlook
3.6. Distribution Channel Outlook
3.7. Region Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Demand and Significance of Hepatitis, Cancer, and Multiple Sclerosis Drug Globally
5.1.1.2. Prevalence of Complex Chronic Condition
5.1.1.3. Need for Extensive Reach and Fast Shipping
5.1.1.4. Government Support for Drug Development for Serious or Life-Threatening Disorders
5.1.2. Restraints
5.1.2.1. Steep Prices of the Drugs
5.1.2.2. Limited Reimbursement Options
5.1.3. Opportunities
5.1.3.1. Patient Assistance Programs to Help Patients Afford their Treatments
5.1.3.2. Cold Chain Management for Temperature Monitoring and Sophisticated Environment System
5.1.4. Challenges
5.1.4.1. Changing Regulatory Framework
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Specialty Drug Distribution Market, by Distribution Type
6.1. Introduction
6.2. Clinic/ASCs
6.3. Home Health
6.4. Inpatient
6.5. Mail Delivery
6.6. Outpatient
6.7. Retail

7. Specialty Drug Distribution Market, by Type
7.1. Introduction
7.2. Full line Wholesalers
7.3. Specialty Distributors

8. Specialty Drug Distribution Market, by Indication
8.1. Introduction
8.2. AIDS
8.3. Hemophilia
8.4. Multiple Sclerosis
8.5. Oncology
8.6. Rheumatoid Arthritis

9. Specialty Drug Distribution Market, by Distribution Channel
9.1. Introduction
9.2. Hospitals & Care Providers
9.3. Independent Pharmacies
9.4. Large Chain Pharmacies
9.5. Online Stores
9.6. Specialty Pharmacies

10. Americas Specialty Drug Distribution Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Specialty Drug Distribution Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand

12. Europe, Middle East & Africa Specialty Drug Distribution Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Quadrant
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Alliance Healthcare
14.2. AmerisourceBergen Corporation
14.3. Cardinal Health, Inc.
14.4. CuraScript, Inc.
14.5. CVS Health Corporation
14.6. Diplomat Pharmacy, Inc.
14.7. Express Scripts Holding Company
14.8. McKesson Corporation
14.9. Mediceo Paltac Holdings Co., Ltd.
14.10. Pfizer Inc.
14.11. Shanghai Pharma
14.12. Sinopharm
14.13. Smith Drug Co., Inc.

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 2. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2020 (USD MILLION)
FIGURE 3. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 4. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
FIGURE 5. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD MILLION)
FIGURE 6. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 7. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: MARKET DYNAMICS
FIGURE 9. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 10. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2020 VS 2025 (%)
FIGURE 11. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2025
FIGURE 13. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CLINIC/ASCS, 2018-2025 (USD MILLION)
FIGURE 14. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CLINIC/ASCS, BY REGION, 2020 VS 2025 (USD MILLION)
FIGURE 15. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTH, 2018-2025 (USD MILLION)
FIGURE 16. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTH, BY REGION, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INPATIENT, 2018-2025 (USD MILLION)
FIGURE 18. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INPATIENT, BY REGION, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MAIL DELIVERY, 2018-2025 (USD MILLION)
FIGURE 20. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MAIL DELIVERY, BY REGION, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY OUTPATIENT, 2018-2025 (USD MILLION)
FIGURE 22. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY OUTPATIENT, BY REGION, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL, 2018-2025 (USD MILLION)
FIGURE 24. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL, BY REGION, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 26. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2025
FIGURE 28. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY FULL LINE WHOLESALERS, 2018-2025 (USD MILLION)
FIGURE 29. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY FULL LINE WHOLESALERS, BY REGION, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY DISTRIBUTORS, 2018-2025 (USD MILLION)
FIGURE 31. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY DISTRIBUTORS, BY REGION, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2020 VS 2025 (%)
FIGURE 33. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2025
FIGURE 35. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AIDS, 2018-2025 (USD MILLION)
FIGURE 36. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AIDS, BY REGION, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEMOPHILIA, 2018-2025 (USD MILLION)
FIGURE 38. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEMOPHILIA, BY REGION, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2025 (USD MILLION)
FIGURE 40. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2020 VS 2025 (USD MILLION)
FIGURE 41. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONCOLOGY, 2018-2025 (USD MILLION)
FIGURE 42. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONCOLOGY, BY REGION, 2020 VS 2025 (USD MILLION)
FIGURE 43. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2025 (USD MILLION)
FIGURE 44. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2020 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (%)
FIGURE 46. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (USD MILLION)
FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025
FIGURE 48. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, 2018-2025 (USD MILLION)
FIGURE 49. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2020 VS 2025 (USD MILLION)
FIGURE 50. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDEPENDENT PHARMACIES, 2018-2025 (USD MILLION)
FIGURE 51. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2020 VS 2025 (USD MILLION)
FIGURE 52. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY LARGE CHAIN PHARMACIES, 2018-2025 (USD MILLION)
FIGURE 53. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY LARGE CHAIN PHARMACIES, BY REGION, 2020 VS 2025 (USD MILLION)
FIGURE 54. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE STORES, 2018-2025 (USD MILLION)
FIGURE 55. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE STORES, BY REGION, 2020 VS 2025 (USD MILLION)
FIGURE 56. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2025 (USD MILLION)
FIGURE 57. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2020 VS 2025 (USD MILLION)
FIGURE 58. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 59. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 60. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 61. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 62. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 63. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 64. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 65. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 66. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 67. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 68. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 69. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 70. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 71. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 72. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 73. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 74. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 75. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 76. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 77. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 78. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 79. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 80. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 81. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 82. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 83. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 84. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 85. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 86. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: FPNV POSITIONING MATRIX
FIGURE 87. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: SHARE, BY QUADRANT, 2020
FIGURE 88. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 4. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD MILLION)
TABLE 5. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CLINIC/ASCS, BY REGION, 2018-2025 (USD MILLION)
TABLE 6. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTH, BY REGION, 2018-2025 (USD MILLION)
TABLE 7. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INPATIENT, BY REGION, 2018-2025 (USD MILLION)
TABLE 8. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MAIL DELIVERY, BY REGION, 2018-2025 (USD MILLION)
TABLE 9. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2025 (USD MILLION)
TABLE 10. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL, BY REGION, 2018-2025 (USD MILLION)
TABLE 11. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD MILLION)
TABLE 12. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY FULL LINE WHOLESALERS, BY REGION, 2018-2025 (USD MILLION)
TABLE 13. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY DISTRIBUTORS, BY REGION, 2018-2025 (USD MILLION)
TABLE 14. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD MILLION)
TABLE 15. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AIDS, BY REGION, 2018-2025 (USD MILLION)
TABLE 16. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEMOPHILIA, BY REGION, 2018-2025 (USD MILLION)
TABLE 17. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2025 (USD MILLION)
TABLE 18. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2025 (USD MILLION)
TABLE 19. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2025 (USD MILLION)
TABLE 20. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD MILLION)
TABLE 21. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2025 (USD MILLION)
TABLE 22. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2025 (USD MILLION)
TABLE 23. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY LARGE CHAIN PHARMACIES, BY REGION, 2018-2025 (USD MILLION)
TABLE 24. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2025 (USD MILLION)
TABLE 25. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2018-2025 (USD MILLION)
TABLE 26. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 27. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 28. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 29. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 30. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 31. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 32. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 33. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 34. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 35. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 36. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 37. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 38. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 39. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 40. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 41. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 42. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 43. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 44. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 45. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 46. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 47. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 48. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 49. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 50. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 51. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 52. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 53. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2025 (USD MILLION)
TABLE 54. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: SCORES
TABLE 55. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: BUSINESS STRATEGY
TABLE 56. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: PRODUCT SATISFACTION
TABLE 57. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: RANKING
TABLE 58. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: SHARE, BY QUADRANT, 2020
TABLE 59. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: MERGER & ACQUISITION
TABLE 60. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 61. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 62. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: INVESTMENT & FUNDING
TABLE 63. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 64. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Alliance Healthcare
  • AmerisourceBergen Corporation
  • Cardinal Health, Inc.
  • CuraScript, Inc.
  • CVS Health Corporation
  • Diplomat Pharmacy, Inc.
  • Express Scripts Holding Company
  • McKesson Corporation
  • Mediceo Paltac Holdings Co., Ltd.
  • Pfizer Inc.
  • Shanghai Pharma
  • Sinopharm
  • Smith Drug Co., Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll